Literature DB >> 8508266

The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: a prospective study during the first three years of the disease.

M A van Leeuwen1, M H van Rijswijk, D M van der Heijde, G J Te Meerman, P L van Riel, P M Houtman, L B van De Putte, P C Limburg.   

Abstract

Studies on the relationship between acute-phase protein (APP) production, clinical disease activity and progression of radiological damage in RA have been hampered by three factors: patients are studied at different stages of the disease; APP levels are taken incidentally rather than serially; and inter-individual differences in the relationship between the extent of the acute-phase reaction and the progression of radiological damage are not accounted for. A group of 110 newly diagnosed (complaints < 1 year) patients with RA were analysed for a follow-up period of at least three years. Damage was assessed radiologically according to the modified method of Sharp. As radiological progression is a cumulative event, APP production was also calculated by plotting serial CRP levels over time. Overall, a highly significant correlation was found between CRP production and radiological progression; however, a wide variation was observed due to inter-individual differences. The greatest variation was found in the lower range of CRP values, where inter-individual variation could not be accounted for by HLA-DR4, positive RF, sex or age. In conclusion, the prognostic use of serial measurement of APPs for the assessment of radiological progression is limited due to inter-individual variation. Knowledge of the factors underlying these inter-individual differences will increase the applicability of CRP in the prediction of joint damage for individual patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8508266     DOI: 10.1093/rheumatology/32.suppl_3.9

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  33 in total

1.  Is DAS28-CRP with three and four variables interchangeable in individual patients selected for biological treatment in daily clinical practice?

Authors:  Ole Rintek Madsen
Journal:  Clin Rheumatol       Date:  2011-09-29       Impact factor: 2.980

2.  Great expectations of modern RA treatment.

Authors:  S Irvine; H C Capell
Journal:  Ann Rheum Dis       Date:  2005-09       Impact factor: 19.103

3.  [Austrian expert opinion on the standard for expert assessment of course of illness in patients with chronic polyarthritis (rheumatoid arthritis)].

Authors:  Klaus P Machold; Hans Peter Brezinsek; Burkhard F Leeb; Stephan Pflugbeil; Franz Rainer; Franz Singer; Martin Skoumal; Tanja A Stamm; Manfred Herold
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

Review 4.  Mechanistic biomarkers for clinical decision making in rheumatic diseases.

Authors:  William H Robinson; Tamsin M Lindstrom; Regina K Cheung; Jeremy Sokolove
Journal:  Nat Rev Rheumatol       Date:  2013-02-19       Impact factor: 20.543

5.  Updating the OMERACT filter: implications for imaging and soluble biomarkers.

Authors:  Maria-Antonietta D'Agostino; Maarten Boers; John Kirwan; Désirée van der Heijde; Mikkel Østergaard; Georg Schett; Robert B Landewé; Walter P Maksymowych; Esperanza Naredo; Maxime Dougados; Annamaria Iagnocco; Clifton O Bingham; Peter M Brooks; Dorcas E Beaton; Frederique Gandjbakhch; Laure Gossec; Francis Guillemin; Sarah E Hewlett; Margreet Kloppenburg; Lyn March; Philip J Mease; Ingrid Moller; Lee S Simon; Jasvinder A Singh; Vibeke Strand; Richard J Wakefield; George A Wells; Peter Tugwell; Philip G Conaghan
Journal:  J Rheumatol       Date:  2014-03-01       Impact factor: 4.666

6.  Predictors of radiographic joint damage in patients with early rheumatoid arthritis.

Authors:  L M Jansen; I E van der Horst-Bruinsma; D van Schaardenburg; P D Bezemer; B A Dijkmans
Journal:  Ann Rheum Dis       Date:  2001-10       Impact factor: 19.103

7.  MRI of the wrist in early rheumatoid arthritis can be used to predict functional outcome at 6 years.

Authors:  N Benton; N Stewart; J Crabbe; E Robinson; S Yeoman; F M McQueen
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

8.  T cells, fibroblast-like synoviocytes, and granzyme B+ cytotoxic cells are associated with joint damage in patients with recent onset rheumatoid arthritis.

Authors:  M C Kraan; J J Haringman; H Weedon; E C Barg; M D Smith; M J Ahern; T J M Smeets; F C Breedveld; P P Tak
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

Review 9.  Biomarkers in rheumatic diseases: how can they facilitate diagnosis and assessment of disease activity?

Authors:  Chandra Mohan; Shervin Assassi
Journal:  BMJ       Date:  2015-11-26

10.  Cartilage Oligomeric Matrix Protein (COMP): A Biomarker of Arthritis.

Authors:  Susan Tseng; A Hari Reddi; Paul E Di Cesare
Journal:  Biomark Insights       Date:  2009-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.